Parse Biosciences

Parse Biosciences is a life sciences company based in Seattle, Washington, dedicated to advancing human health and scientific research. Founded in 2021, the company leverages technology developed at the University of Washington to enable researchers to conduct single cell sequencing with remarkable scale and simplicity. The company’s flagship product, the Evercode combinatorial barcoding system, allows for the profiling of 1,000 to 1 million cells or nuclei in a single experiment. The Evercode platform includes solutions such as Evercode Whole Transcriptome for comprehensive single cell sequencing and Evercode Immune Profiling for immune system applications. Parse Biosciences serves over 1,000 labs globally, including major pharmaceutical companies and research institutions across various regions. In December 2023, Parse Biosciences secured $50 million in financing to support its growth and has established a new 34,000 square foot headquarters and laboratory in Seattle's South Lake Union district.